Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 26.17
    Last
  • 0.15  0.58%
    Today's Change
  • 26.02
    Previous Close
  • Today
     
    9.51
    26.36
    52 Week Low - High
8:10 pm ET 9/23/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding50 million
Market Cap$1 billion
Return on Equity ttm21.45%
Last DividendSUPN:US does not pay a dividend
Earnings
EPS: Year Actual ttm0.484
EPS: Year Est. 12/16 ttm0.708
 
EPS: Quarterly Actual 6/16 0.19
EPS: Quarterly Est. 9/16 0.19
 
Price/Earnings ttm54.03
Relative Price/Earnings2.651
Earnings Growth Rate-36.17
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$144 million
Net Income$14 million
Total Assets$189 million
Employees344
Web Sitewww.supernus.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!